Literature DB >> 7916076

Mediation of renal cyst formation by hepatocyte growth factor.

S Horie1, E Higashihara, K Nutahara, Y Mikami, A Okubo, M Kano, K Kawabe.   

Abstract

Hepatocyte growth factor (HGF) is a potent mitogen for renal tubular cells, and HGF and its receptor (c-met proto-oncogene product, Met) can induce lumen formation in epithelial cells. We measured the concentration of HGF in cyst fluids from patients with renal cystic diseases. The concentration of HGF was high in proximal cyst fluid (mean 2.45 vs 0.42 ng/mL in distal cysts). Cyclic AMP concentration was higher in distal than in proximal cysts (663 vs 6.0 pmol/L). mRNA of HGF and Met were co-expressed in cyst walls from cases with polycystic kidney disease. These findings suggest that HGF is a growth factor that may mediate human renal cyst genesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7916076     DOI: 10.1016/s0140-6736(94)92344-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  18 in total

1.  Polycystin-1 regulates STAT activity by a dual mechanism.

Authors:  Jeffrey J Talbot; Jonathan M Shillingford; Shivakumar Vasanth; Nicholas Doerr; Sambuddho Mukherjee; Mike T Kinter; Terry Watnick; Thomas Weimbs
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

Review 2.  ADPKD: molecular characterization and quest for treatment.

Authors:  Shigeo Horie
Journal:  Clin Exp Nephrol       Date:  2005-12       Impact factor: 2.801

3.  Dome formation and tubule morphogenesis by Xenopus kidney A6 cell cultures exposed to microgravity simulated with a 3D-clinostat and to hypergravity.

Authors:  J Ichigi; M Asashima
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-01       Impact factor: 2.416

4.  Exploitation of the Polymeric Immunoglobulin Receptor for Antibody Targeting to Renal Cyst Lumens in Polycystic Kidney Disease.

Authors:  Erin E Olsan; Tamami Matsushita; Mina Rezaei; Thomas Weimbs
Journal:  J Biol Chem       Date:  2015-04-28       Impact factor: 5.157

Review 5.  Renal Toxicities of Targeted Therapies.

Authors:  Anum Abbas; Mohsin M Mirza; Apar Kishor Ganti; Ketki Tendulkar
Journal:  Target Oncol       Date:  2015-12       Impact factor: 4.493

6.  Failure to ubiquitinate c-Met leads to hyperactivation of mTOR signaling in a mouse model of autosomal dominant polycystic kidney disease.

Authors:  Shan Qin; Mary Taglienti; Surya M Nauli; Leah Contrino; Ayumi Takakura; Jing Zhou; Jordan A Kreidberg
Journal:  J Clin Invest       Date:  2010-09-13       Impact factor: 14.808

Review 7.  The renal effects of ALK inhibitors.

Authors:  Hassan Izzedine; Rania Kheder El-Fekih; Mark A Perazella
Journal:  Invest New Drugs       Date:  2016-07-29       Impact factor: 3.850

8.  STAT3 Signaling in Polycystic Kidney Disease.

Authors:  Thomas Weimbs; Jeffrey J Talbot
Journal:  Drug Discov Today Dis Mech       Date:  2013-12-01

9.  Pkd1 inactivation induced in adulthood produces focal cystic disease.

Authors:  Ayumi Takakura; Leah Contrino; Alexander W Beck; Jing Zhou
Journal:  J Am Soc Nephrol       Date:  2008-09-05       Impact factor: 10.121

Review 10.  Regulation of STATs by polycystin-1 and their role in polycystic kidney disease.

Authors:  Thomas Weimbs; Erin E Olsan; Jeffrey J Talbot
Journal:  JAKSTAT       Date:  2013-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.